David Kerr: Angry bird medicine

“I want this company to be bigger than Sanofi-Aventis in ten years time” was the opening line from a (successful) entrepreneur I met the other day. He might be right given the resources being poured into creating technology for the healthcare market here in Silicon Valley these days. The concept is straightforward – choose a […]

Read More…

David Kerr: Deus ex machina

Forget complementary therapies, the big question is can engineering succeed where traditional medicine has failed? Anyone following the online technology bible “TechCrunch” might be persuaded by this idea. Here in the US and on the West Coast in particular, the belief is growing that the combination of money and mathematical and engineering brilliance (and also […]

Read More…